Print

Elsevier Business Intelligence's "IN3 Medical Device 360° Boston" Conference to Feature Exceptional Line-Up of Start-Up Presenters and Top-Tier Investors  
6/12/2012 8:44:28 AM

BOSTON, MA--(Marketwire - June 12, 2012) - Elsevier Business Intelligence, publisher of "The Gray Sheet" and the medtech industry's leading provider of strategic partnership and investment conferences, will host an outstanding program of top-tier international device investors, business development decision-makers and innovative start-ups at its "Investment in Innovation (IN3) Medical Device 360° Boston" strategic partnering and investment conference, June 27-29, 2012, at the Hyatt Regency Boston in downtown Boston, Massachusetts.

IN3 Medical Device 360° Boston will feature presentations by more than 30 stealth mode- to commercial-stage start-ups that are seeking funding and/or strategic partnership, developing products covering the spectrum of diagnostic and therapeutic device markets. Presenters confirmed to date include Aeon Astron Europe BV, Aerolase, CerviLenz, CoolSpine, Cortical Dynamics, EndoPhlebex Technologies, Genomind, InfanDx, MGI Medical, NeoChord, Neuronetrix, Poiesis Medical, Soft Tissue Regeneration, StnDrd Infusion, Stroma Medical, Suspension Orthopaedic Solutions, Therapeutic Monitoring Solutions, Thermedx, Thermimage, ThermopeutiX, Tibion, Titan Spine, TrueVision 3D Surgical, Vascular Access Technologies, Vertiflex, and Waveline Medical.

The event also will feature an outstanding agenda of expert panels and presentations designed to give all attendees a full 360° view of the most pressing issues facing the global device industry in 2012 and beyond. Confirmed participating speakers include senior-level strategic decision makers from Ascent Biomedical Ventures, Biomet, Boston Scientific, Covidien, Cowen Healthcare Royalty Partners, DePuy Mitek and Codman/Johnson & Johnson, Fidelity Biosciences, NGN Capital, NMT Capital, Novartis Venture Funds, Polaris Venture Partners, Siemens Venture Capital, Smith & Nephew Endoscopy, SV Life Sciences Advisers, Wright Medical Technology, and many more. Interactive panel topics will include: Intellectual Property's Role in Start-Up Valuations, What Big Companies Want to See in a Start-Up Before Buying; Complying with the New Physician Sunshine Law; and Medtech Investing: Hear What It Takes to Get a VC to Say Yes. In addition, Don Urbanowicz, Principal, Urbanowicz Consulting, will give a special evening presentation on Top 10 Value Drivers Strategics Look for in Pre-Revenue Startups, and Robert Pearson, president of W20 Group, will give a Social Media Keynote Presentation. A networking cocktail reception will be held the evening of June 28th. Partnering software will be available to all registered attendees prior to the conference so that one-on-one onsite meetings can be pre-arranged.

In addition to all of the customary IN3 conference benefits, presenting company CEOs have the opportunity to be interviewed on camera, at no charge, for a 3-minute exclusive video in which they may discuss their company and technology. This professionally produced interview will be featured post-conference at www.in3tv.com. Various ongoing IN3 conference promotions in the future will link back to in3tv.com, and presenting companies themselves will be able to link to their in3tv.com video from their website for ongoing use. All of the one-on-one interviews with presenting-company CEOs will take place at, and during, the IN3 Boston conference and be organized by medtech PR/IR expert Ronald Trahan, President of Ronald Trahan Associates, Inc. Videotaping will take place on a 'walk-in' basis on only one day of the conference: Thursday, June 28th. Questions about the videotaping of interviews may be directed to Ronald Trahan: rctrahan@ronaldtrahan.com, 508-359-4005, ext. 108.

Emerging medtech companies that would like to apply to present in Boston should contact Kayleen Kell at 949-797-7142, or email k.kell@elsevier.com.

The event will be held at the Hyatt Regency Boston, centrally located in downtown Boston. Co-sponsors include Ronald Trahan Associates Inc., Aptiv Solutions, Medmarc with The Hartford and Biomedic-Insure, UBM TechInsights, Neocure Group, Mass Medical Angels, Life Science Intelligence, Current Partnering and Marketwire. Visit www.IN3Boston.com for full conference and registration details. EBI will be hosting one additional IN3 Medical Device 360° event in 2012, its Summit-San Francisco, October 15-17; visit http://www.elsevierbi.com/conferences for more information.

About Elsevier Business Intelligence
Elsevier Business Intelligence (EBI), an Elsevier company built on the heritage of F-D-C Reports, Windhover Information and Medtech Insight, is a global information supplier providing business intelligence on regulatory, business and reimbursement issues that are vital to the healthcare industry. Through a range of products including publications, conferences, databases and reports, EBI places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge, by providing the perfect combination of news and information together with penetrating insight and analysis. EBI (www.elsevierbi.com) has offices in the U.S. in Bridgewater, N.J.; Norwalk, Conn.; Rockville, Md.; and Irvine, Calif.


Contact:
Ronald Trahan, APR
Ronald Trahan Associates Inc.
508-359-4005, x108


//-->